CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 16 enrolled
Drug / intervention
oral cromolyn sodium +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02371941
NCT02371941Phase 4Completed
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled Study of the Use of Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis

University of Tennessee·interventional·Posted Feb 26, 2015·Updated Oct 26, 2023

In Brief

A Phase 4 clinical trial evaluating oral cromolyn sodium and Placebo for Eosinophilic Esophagitis. Completed, enrolled 16 participants across 1 site.

Detailed Summary

This is a randomized, double-blind, placebo-controlled study of oral cromolyn sodium when made into a viscous preparation for the treatment of eosinophilic esophagitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEosinophilic Esophagitis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 26, 2015
Enrollment StartDec 1, 2014
Primary CompletionJul 1, 2017
Study CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 11.3 years ago

Interventions

oral cromolyn sodiumdrug

Oral cromolyn sodium

Placebodrug

Saline